table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Immunotherapy Market Size Analysis from 2023 to 2028
1.5.1 Global Immunotherapy Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Immunotherapy Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Immunotherapy Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Immunotherapy Industry Impact
Chapter 2 Global Immunotherapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Immunotherapy (Volume and Value) by Type
2.1.1 Global Immunotherapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global Immunotherapy Revenue and Market Share by Type (2017-2022)
2.2 Global Immunotherapy (Volume and Value) by Application
2.2.1 Global Immunotherapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global Immunotherapy Revenue and Market Share by Application (2017-2022)
2.3 Global Immunotherapy (Volume and Value) by Regions
2.3.1 Global Immunotherapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Immunotherapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Immunotherapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Immunotherapy Consumption by Regions (2017-2022)
4.2 North America Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America Immunotherapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Immunotherapy Market Analysis
5.1 North America Immunotherapy Consumption and Value Analysis
5.1.1 North America Immunotherapy Market Under COVID-19
5.2 North America Immunotherapy Consumption Volume by Types
5.3 North America Immunotherapy Consumption Structure by Application
5.4 North America Immunotherapy Consumption by Top Countries
5.4.1 United States Immunotherapy Consumption Volume from 2017 to 2022
5.4.2 Canada Immunotherapy Consumption Volume from 2017 to 2022
5.4.3 Mexico Immunotherapy Consumption Volume from 2017 to 2022
Chapter 6 East Asia Immunotherapy Market Analysis
6.1 East Asia Immunotherapy Consumption and Value Analysis
6.1.1 East Asia Immunotherapy Market Under COVID-19
6.2 East Asia Immunotherapy Consumption Volume by Types
6.3 East Asia Immunotherapy Consumption Structure by Application
6.4 East Asia Immunotherapy Consumption by Top Countries
6.4.1 China Immunotherapy Consumption Volume from 2017 to 2022
6.4.2 Japan Immunotherapy Consumption Volume from 2017 to 2022
6.4.3 South Korea Immunotherapy Consumption Volume from 2017 to 2022
Chapter 7 Europe Immunotherapy Market Analysis
7.1 Europe Immunotherapy Consumption and Value Analysis
7.1.1 Europe Immunotherapy Market Under COVID-19
7.2 Europe Immunotherapy Consumption Volume by Types
7.3 Europe Immunotherapy Consumption Structure by Application
7.4 Europe Immunotherapy Consumption by Top Countries
7.4.1 Germany Immunotherapy Consumption Volume from 2017 to 2022
7.4.2 UK Immunotherapy Consumption Volume from 2017 to 2022
7.4.3 France Immunotherapy Consumption Volume from 2017 to 2022
7.4.4 Italy Immunotherapy Consumption Volume from 2017 to 2022
7.4.5 Russia Immunotherapy Consumption Volume from 2017 to 2022
7.4.6 Spain Immunotherapy Consumption Volume from 2017 to 2022
7.4.7 Netherlands Immunotherapy Consumption Volume from 2017 to 2022
7.4.8 Switzerland Immunotherapy Consumption Volume from 2017 to 2022
7.4.9 Poland Immunotherapy Consumption Volume from 2017 to 2022
Chapter 8 South Asia Immunotherapy Market Analysis
8.1 South Asia Immunotherapy Consumption and Value Analysis
8.1.1 South Asia Immunotherapy Market Under COVID-19
8.2 South Asia Immunotherapy Consumption Volume by Types
8.3 South Asia Immunotherapy Consumption Structure by Application
8.4 South Asia Immunotherapy Consumption by Top Countries
8.4.1 India Immunotherapy Consumption Volume from 2017 to 2022
8.4.2 Pakistan Immunotherapy Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Immunotherapy Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Immunotherapy Market Analysis
9.1 Southeast Asia Immunotherapy Consumption and Value Analysis
9.1.1 Southeast Asia Immunotherapy Market Under COVID-19
9.2 Southeast Asia Immunotherapy Consumption Volume by Types
9.3 Southeast Asia Immunotherapy Consumption Structure by Application
9.4 Southeast Asia Immunotherapy Consumption by Top Countries
9.4.1 Indonesia Immunotherapy Consumption Volume from 2017 to 2022
9.4.2 Thailand Immunotherapy Consumption Volume from 2017 to 2022
9.4.3 Singapore Immunotherapy Consumption Volume from 2017 to 2022
9.4.4 Malaysia Immunotherapy Consumption Volume from 2017 to 2022
9.4.5 Philippines Immunotherapy Consumption Volume from 2017 to 2022
9.4.6 Vietnam Immunotherapy Consumption Volume from 2017 to 2022
9.4.7 Myanmar Immunotherapy Consumption Volume from 2017 to 2022
Chapter 10 Middle East Immunotherapy Market Analysis
10.1 Middle East Immunotherapy Consumption and Value Analysis
10.1.1 Middle East Immunotherapy Market Under COVID-19
10.2 Middle East Immunotherapy Consumption Volume by Types
10.3 Middle East Immunotherapy Consumption Structure by Application
10.4 Middle East Immunotherapy Consumption by Top Countries
10.4.1 Turkey Immunotherapy Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Immunotherapy Consumption Volume from 2017 to 2022
10.4.3 Iran Immunotherapy Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Immunotherapy Consumption Volume from 2017 to 2022
10.4.5 Israel Immunotherapy Consumption Volume from 2017 to 2022
10.4.6 Iraq Immunotherapy Consumption Volume from 2017 to 2022
10.4.7 Qatar Immunotherapy Consumption Volume from 2017 to 2022
10.4.8 Kuwait Immunotherapy Consumption Volume from 2017 to 2022
10.4.9 Oman Immunotherapy Consumption Volume from 2017 to 2022
Chapter 11 Africa Immunotherapy Market Analysis
11.1 Africa Immunotherapy Consumption and Value Analysis
11.1.1 Africa Immunotherapy Market Under COVID-19
11.2 Africa Immunotherapy Consumption Volume by Types
11.3 Africa Immunotherapy Consumption Structure by Application
11.4 Africa Immunotherapy Consumption by Top Countries
11.4.1 Nigeria Immunotherapy Consumption Volume from 2017 to 2022
11.4.2 South Africa Immunotherapy Consumption Volume from 2017 to 2022
11.4.3 Egypt Immunotherapy Consumption Volume from 2017 to 2022
11.4.4 Algeria Immunotherapy Consumption Volume from 2017 to 2022
11.4.5 Morocco Immunotherapy Consumption Volume from 2017 to 2022
Chapter 12 Oceania Immunotherapy Market Analysis
12.1 Oceania Immunotherapy Consumption and Value Analysis
12.2 Oceania Immunotherapy Consumption Volume by Types
12.3 Oceania Immunotherapy Consumption Structure by Application
12.4 Oceania Immunotherapy Consumption by Top Countries
12.4.1 Australia Immunotherapy Consumption Volume from 2017 to 2022
12.4.2 New Zealand Immunotherapy Consumption Volume from 2017 to 2022
Chapter 13 South America Immunotherapy Market Analysis
13.1 South America Immunotherapy Consumption and Value Analysis
13.1.1 South America Immunotherapy Market Under COVID-19
13.2 South America Immunotherapy Consumption Volume by Types
13.3 South America Immunotherapy Consumption Structure by Application
13.4 South America Immunotherapy Consumption Volume by Major Countries
13.4.1 Brazil Immunotherapy Consumption Volume from 2017 to 2022
13.4.2 Argentina Immunotherapy Consumption Volume from 2017 to 2022
13.4.3 Columbia Immunotherapy Consumption Volume from 2017 to 2022
13.4.4 Chile Immunotherapy Consumption Volume from 2017 to 2022
13.4.5 Venezuela Immunotherapy Consumption Volume from 2017 to 2022
13.4.6 Peru Immunotherapy Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Immunotherapy Consumption Volume from 2017 to 2022
13.4.8 Ecuador Immunotherapy Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Immunotherapy Business
14.1 Abbvie
14.1.1 Abbvie Company Profile
14.1.2 Abbvie Immunotherapy Product Specification
14.1.3 Abbvie Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Amgen, Inc.
14.2.1 Amgen, Inc. Company Profile
14.2.2 Amgen, Inc. Immunotherapy Product Specification
14.2.3 Amgen, Inc. Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Biogen
14.3.1 Biogen Company Profile
14.3.2 Biogen Immunotherapy Product Specification
14.3.3 Biogen Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Bristol-Myers Squibb
14.4.1 Bristol-Myers Squibb Company Profile
14.4.2 Bristol-Myers Squibb Immunotherapy Product Specification
14.4.3 Bristol-Myers Squibb Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Celgene
14.5.1 Celgene Company Profile
14.5.2 Celgene Immunotherapy Product Specification
14.5.3 Celgene Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Johnson & Johnson
14.6.1 Johnson & Johnson Company Profile
14.6.2 Johnson & Johnson Immunotherapy Product Specification
14.6.3 Johnson & Johnson Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Merck
14.7.1 Merck Company Profile
14.7.2 Merck Immunotherapy Product Specification
14.7.3 Merck Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Novartis
14.8.1 Novartis Company Profile
14.8.2 Novartis Immunotherapy Product Specification
14.8.3 Novartis Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Pfizer
14.9.1 Pfizer Company Profile
14.9.2 Pfizer Immunotherapy Product Specification
14.9.3 Pfizer Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Roche
14.10.1 Roche Company Profile
14.10.2 Roche Immunotherapy Product Specification
14.10.3 Roche Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Immunotherapy Market Forecast (2023-2028)
15.1 Global Immunotherapy Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Immunotherapy Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Immunotherapy Value and Growth Rate Forecast (2023-2028)
15.2 Global Immunotherapy Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Immunotherapy Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Immunotherapy Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Immunotherapy Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Immunotherapy Consumption Forecast by Type (2023-2028)
15.3.2 Global Immunotherapy Revenue Forecast by Type (2023-2028)
15.3.3 Global Immunotherapy Price Forecast by Type (2023-2028)
15.4 Global Immunotherapy Consumption Volume Forecast by Application (2023-2028)
15.5 Immunotherapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
